What is the clinical landscape?
The clinical landscape is a comprehensive view of all clinical research and therapeutic development activity within a particular disease area or indication. It encompasses ongoing, completed, and planned clinical trials, as well as investigational and approved therapies. Key elements of the clinical landscape include study design, endpoints, comparators, patient populations, and trial sponsors. Understanding this landscape provides critical insights into the therapeutic strategies being pursued and the evidence base supporting them.
Why is the clinical landscape important?
Mapping the clinical landscape helps pharmaceutical and biotech companies identify gaps in evidence, differentiate their development programmes, and anticipate regulatory and competitive challenges. It informs clinical trial design, comparator selection, and indication prioritization, and is essential for positioning products within a rapidly evolving treatment environment. For medical and market access teams, understanding the clinical landscape supports engagement with stakeholders, development of value narratives, and evidence generation planning.
